OTCMKTS:SDGCF Sundrug Co.,Ltd. (SDGCF) Stock Price, News & Analysis $28.18 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Sundrug Co.,Ltd. Stock (OTCMKTS:SDGCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sundrug Co.,Ltd. alerts:Sign Up Key Stats Today's Range$28.18▼$28.1850-Day Range$28.18▼$28.1852-Week Range$28.18▼$28.18VolumeN/AAverage Volume2,500 shsMarket CapitalizationN/AP/E Ratio0.12Dividend Yield169.99%Price TargetN/AConsensus RatingN/A Company OverviewSundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It operates drug stores that offers pharmaceuticals, cosmetics, and daily miscellaneous goods; and discount stores that sells foodstuffs, household goods, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.Read More… Sundrug Co.,Ltd. Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreSDGCF MarketRank™: Sundrug Co.,Ltd. scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Sundrug Co.,Ltd.. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.69.Read more about Sundrug Co.,Ltd.'s valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverSundrug Co.,Ltd. has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sundrug Co.,Ltd. has recently increased by 22.31%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldSundrug Co.,Ltd. pays a meaningful dividend of 1.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSundrug Co.,Ltd. does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Sundrug Co.,Ltd. is 20.98%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Sundrug Co.,Ltd.'s dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverSundrug Co.,Ltd. has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sundrug Co.,Ltd. has recently increased by 22.31%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentSundrug Co.,Ltd. has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sundrug Co.,Ltd. this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sundrug Co.,Ltd. insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 25.63% of the stock of Sundrug Co.,Ltd. is held by institutions.Read more about Sundrug Co.,Ltd.'s insider trading history. Receive SDGCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sundrug Co.,Ltd. and its competitors with MarketBeat's FREE daily newsletter. Email Address SDGCF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com SDGCF Stock Analysis - Frequently Asked Questions How have SDGCF shares performed this year? Sundrug Co.,Ltd.'s stock was trading at $28.18 at the start of the year. Since then, SDGCF shares have increased by 0.0% and is now trading at $28.18. View the best growth stocks for 2025 here. How do I buy shares of Sundrug Co.,Ltd.? Shares of SDGCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/03/2025Next Earnings (Estimated)5/15/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:SDGCF CIKN/A Webwww.sundrug.co.jp Phone(142) 369-6211FaxN/AEmployees6,371Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.12 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:SDGCF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sundrug Co.,Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sundrug Co.,Ltd. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.